the market is forward thinking Laurentian analyst was low on reveues.
Here's what to look forward to this year.
Outlook:
WELL's outlook continues to be positive and resilient for 2023. The Company is poised to achieve significant growth while effectively managing its costs and delivering sustained growth in cashflow available to shareholders. Management is pleased to provide the following guidance for 2023:
- Annual revenue between $665 million and $685 million , representing 17% to 20% annual growth as compared to 2022. This revenue guidance only includes announced acquisitions.
-
- Annual Adjusted EBITDA is expected to increase by more than 10% over 2022 levels allowing the company to invest in growth and continue to acquire market share.
WELL's strong organic growth and robust cash flow profile allows the Company to continue to successfully execute on its acquisition plans. Management expects additional cash flows generated by the Company will continue to be re-invested in the business and allocated in a disciplined manner, which may come in the form of further acquisitions, debt repayments, share repurchases, and/or to accelerate organic growth.
WELL is expecting to have strong performance in 2023 across all its business units and for the entire Company as a whole. Despite the current geo-political, inflationary, and turbulent economic environment, the Company does not foresee any material influences or challenges that would impair its ability to deliver solid results in 2023. Many of the key variables inherent in the execution of WELL's business are firmly in its own grasp and not dependent on outside factors.